Research / CRNC / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-054339 General Corporate
Debt relative to revenue 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
249.27% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.49% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.68% · OPTIONAL · VALID
Revenue growth 65th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
11.81% · CORE · VALID
Inventory pressure 40th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
1.15% · OPTIONAL · VALID
Gross margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
76.04% · CORE · VALID
Operating margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
2.69% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
42.02% · OPTIONAL · VALID
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
10.80% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 269.01%
Current 249.27%
Delta -19.75% Capex Intensity Decreased
Previous 0.75%
Current 0.49%
Delta -0.26% Cash Generation Increased
Previous 21.98%
Current 28.68%
Delta 6.71% Growth Increased
Previous -17.71%
Current 11.81%
Delta 29.52% Inventory Pressure Decreased
Previous 1.56%
Current 1.15%
Delta -0.41% Margin Increased
Previous 73.68%
Current 76.04%
Delta 2.36% Profitability Increased
Previous -3.81%
Current 2.69%
Delta 6.50% R And D Intensity Decreased
Previous 47.20%
Current 42.02%
Delta -5.18% Sbc Intensity Increased
Previous 10.52%
Current 10.80%
Delta 0.28% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Mar 31, 2026
Similarity 78%
Compared 9 dimensions
Coverage 100% Growth 45.0 · Margin 25.0 · Profitability 20.0 · Sbc Intensity 5.0 · Capex Intensity 5.0 · Cash Generation 10.0 · R And D Intensity 20.0 · Inventory Pressure 26.7 · Balance Sheet Leverage 0.0 Sep 30, 2024
Similarity 72%
Compared 8 dimensions
Coverage 89% Growth 5.0 · Margin 6.1 · Profitability 49.5 · Sbc Intensity 33.9 · Capex Intensity 15.8 · Cash Generation 42.6 · R And D Intensity 1.3 · Balance Sheet Leverage 19.2 Sep 30, 2023
Similarity 70%
Compared 8 dimensions
Coverage 89% Growth 19.5 · Margin 45.0 · Profitability 40.0 · Sbc Intensity 1.7 · Capex Intensity 6.7 · Cash Generation 50.0 · R And D Intensity 18.3 · Balance Sheet Leverage 15.0 Mar 31, 2025
Similarity 70%
Compared 8 dimensions
Coverage 89% Growth 11.5 · Margin 10.0 · Profitability 30.0 · Sbc Intensity 25.0 · Capex Intensity 60.0 · Cash Generation 0.0 · R And D Intensity 30.0 · Balance Sheet Leverage 30.0 Sep 30, 2025
Similarity 61%
Compared 8 dimensions
Coverage 89% Growth 54.5 · Margin 30.0 · Profitability 10.0 · Sbc Intensity 10.0 · Capex Intensity 85.0 · Cash Generation 0.0 · R And D Intensity 10.0 · Balance Sheet Leverage 30.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.